{"url_path":"/sec/sxtc/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 THE OFFER AND","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1723980/0001213900-26-074310-index.html","accession_number":"0001213900-26-074310","cik":"0001723980","ticker":"SXTC","issuer_name":"China SXT Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1723980/0001213900-26-074310-index.html","primary_entity_key":"0001723980","primary_entity_name":"China SXT Pharmaceuticals, Inc."},"word_count":80,"has_tables":true,"body_markdown":"ITEM 9. THE OFFER AND\nLISTING\n\n \n\n9.A. Offer and Listing Details\n\n \n\nOur Class A Ordinary Shares\nare listed for trading on the NASDAQ Capital Market under the symbol “SXTC” The shares began trading on January 3, 2019 on\nthe NASDAQ Capital Market.\n\n \n\n75\n\n \n\n \n\n9.B. Plan of Distribution\n\n \n\nNot Applicable.\n\n \n\n9.C. Markets\n\n \n\nOur Class A Ordinary Shares\nare currently traded on the NASDAQ Capital Market.\n\n \n\n9.D. Selling Shareholders\n\n \n\nNot Applicable.\n\n \n\n9.E. Dilution\n\n \n\nNot Applicable.\n\n \n\n9.F. Expenses of the Issue\n\n \n\nNot Applicable."}